GlassScriptPhysician profile
Amy Rechenberg
NPI 1851953822
$2,072.45
in general payments reported to CMS, 2019-2025
16 companies · $380 in 2025
The $380 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $437 · 2023: $448 · 2024: $807 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,490 · Education: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,490.40 |
| Education | $144.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $529.25 | 2022-2025 | Micra, Corevalve Evolut R |
| E.R. Squibb & Sons, L.L.C. | $314.41 | 2022-2025 | Camzyos |
| Abbott Laboratories | $291.76 | 2024 | Perclose Proglide, Ensite |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $195.55 | 2022-2024 | Lifevest |
| Kestra Medical Technology Services, INC. | $126.62 | 2024 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.99 | 2024 | Jardiance |
| Bard Peripheral Vascular, INC. | $114.44 | 2024 | Rotarexs 6 F X 135 Cm |
| Boston Scientific Corporation | $78.76 | 2024 | |
| Abiomed | $76.70 | 2022 | |
| Baxter Healthcare | $55.78 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Amgen INC. | $51.65 | 2023-2024 | Repatha |
| Heartflow, INC. | $33.06 | 2023 | Ffrct |
| Atricure, INC. | $25.12 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Astrazeneca Pharmaceuticals LP | $19.46 | 2023 | Farxiga |
| Novo Nordisk INC | $18.74 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $16.16 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Rechenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.